Large Volume Wearable Injectors; Used To Deliver Drugs Large Volume of Drugs such as Biologicals

 

Large Volume Wearable Injectors
Large Volume Wearable Injectors

Large volume wearable injectors are medical devices used to deliver high volume of drugs usually in the range of 2-50 ml of drug within 2-15 minutes. As a result, medical device industry has come up with several wearable injectors suitable for the delivery of such molecules. These injectors offer numerous dosing options (continuous, bolus, or basal), integrated safety mechanisms, along with no or minimal risk of needlestick injuries. They have become a preferred choice for administration of drugs in home-care setting and can be used for the subcutaneous drug delivery.

Ultra large volume wearable injectors are used to deliver large volume of drugs. They are designed to deliver the drugs subcutaneously over an extended period of time. Such injectors have the drug solution reservoir with a capacity of 2ml or more. Large volume injectors are commonly used for rapid administration of biologic drug formulations, mainly those contain monoclonal antibodies as the biologic formulation is viscous at high concentration. Biologics have high viscosity and cannot be administered in lower volume, and thus delivered by large volume injectors.

Variants of these wearable devices have been designed to administer highly viscous drugs (such as biologics) in large volumes (more than 1 mL), offering numerous dosing options. Large volume injectors offer a solution to patients suffering from both chronic and non-communicable diseases. They can be used for continuous dosing and bolus dosing. Some of the features of these devices include error alerts, visual/aid drug delivery confirmation notifications, and connectivity to web-based portals. These features help increase patient compliance and reduce pain.

Large volume wearable injectors are often used in the treatment of chronic diseases, such as cancer, diabetes, and autoimmune disorders. Chronic diseases are a public health emergency in Mexico, and chronic diseases are primary cause of death worldwide, leading to more deaths annually than all other causes combined. Thus, with the increase in burden of aforementioned diseases, the usage of large volume injectors is also increasing rapidly.

Comments

Post a Comment

Popular posts from this blog

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular t...
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories ...
Read more

Organic Milk Has Much Higher Concentration Of Iron, Vitamin E, And Polyunsaturated Fatty Acids Omega-3 And Omega-6 As Compared To Regular Milk

Image
  Organic Milk Organic Milk is milk made from livestock raised using organic farming practices. The use of the term "organic" is regulated by food authorities in most jurisdictions. Organic cows are not allowed to be given hormones, which stimulate milk production. Organic feed also must be grown without the use of synthetic pesticides. Organic cows must get a certain percentage of their diet from grazing, although most organic dairies supplement the grass with grain. However, organic grazing cows produce less milk than cows that eat a grain-based diet. Buying organic milk may be a better investment for your health. According to Coherent Market Insights the Organic Milk Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. The standards for organic milk are stringent. To meet the organic standard, a dairy farm cannot use any form of animal growth hormones or antibiotics. Organic cows must spend at least 30% of their lives on pasture. C...
Read more